FR2426695A1 - Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique - Google Patents
Nouvelles cephalosporines, leur procede de preparation et leur application therapeutiqueInfo
- Publication number
- FR2426695A1 FR2426695A1 FR7913531A FR7913531A FR2426695A1 FR 2426695 A1 FR2426695 A1 FR 2426695A1 FR 7913531 A FR7913531 A FR 7913531A FR 7913531 A FR7913531 A FR 7913531A FR 2426695 A1 FR2426695 A1 FR 2426695A1
- Authority
- FR
- France
- Prior art keywords
- preparation process
- therapeutic application
- cephalosporins
- new cephalosporins
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
L'invention concerne des céphalosporines. L'invention a plus particulièrement pour objet des composés de la formule générale 1 dans laquelle R**a et R** b identiques ou différents représentent chacun un groupe alkyle en C1 à C4 ou forment un groupe cycloalkylidène en C3 -C7 avec l'atome de carbone auquel ils sont attachés et R**4 représente un atome d'hydrogène ou un groupe 4-carbamoyle. L'invention concerne aussi les sels et les esters métaboliquement labiles atoxiques des composés en question qui constituent des antibiotiques de valeur.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2291378 | 1978-05-26 | ||
GB2291178 | 1978-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2426695A1 true FR2426695A1 (fr) | 1979-12-21 |
FR2426695B1 FR2426695B1 (fr) | 1982-06-11 |
Family
ID=26256190
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7913531A Granted FR2426695A1 (fr) | 1978-05-26 | 1979-05-28 | Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique |
FR8007929A Granted FR2445835A1 (fr) | 1978-05-26 | 1980-04-09 | Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8007929A Granted FR2445835A1 (fr) | 1978-05-26 | 1980-04-09 | Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique |
Country Status (27)
Country | Link |
---|---|
US (2) | US4258041A (fr) |
AR (2) | AR229883A1 (fr) |
AT (1) | AT370420B (fr) |
AU (1) | AU524671B2 (fr) |
CA (1) | CA1127633A (fr) |
CH (2) | CH646178A5 (fr) |
DE (1) | DE2921316C2 (fr) |
DK (1) | DK157685C (fr) |
ES (2) | ES480914A1 (fr) |
FI (2) | FI67555C (fr) |
FR (2) | FR2426695A1 (fr) |
HK (1) | HK40183A (fr) |
IE (2) | IE49172B1 (fr) |
IL (3) | IL57400A (fr) |
IT (1) | IT1116198B (fr) |
KE (1) | KE3252A (fr) |
LU (1) | LU81319A1 (fr) |
MY (1) | MY8400017A (fr) |
NL (2) | NL176855C (fr) |
NO (2) | NO155347C (fr) |
NZ (2) | NZ190558A (fr) |
PH (1) | PH16961A (fr) |
PT (2) | PT69670A (fr) |
SE (2) | SE438507B (fr) |
SG (1) | SG58382G (fr) |
SI (2) | SI7911231A8 (fr) |
YU (2) | YU41635B (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2465737A1 (fr) * | 1979-04-12 | 1981-03-27 | Squibb & Sons Inc | 7-(2-(2-amino-4-thiazolyl)-2 - ((1-carboxy-1,1 - dialkyl)alcoxyimino)acetamido)cephem sulfoxydes a action antibacterienne |
FR2476647A2 (fr) * | 1980-02-26 | 1981-08-28 | Roussel Uclaf | Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn |
EP0044238A1 (fr) * | 1980-06-30 | 1982-01-20 | Sanofi S.A. | Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant |
FR2560879A1 (fr) * | 1984-03-09 | 1985-09-13 | Glaxo Group Ltd | Procede de recuperation de l'antibiotique ceftazidime |
EP0192210A2 (fr) * | 1985-02-18 | 1986-08-27 | Fujisawa Pharmaceutical Co., Ltd. | Composés céphem et procédés pour leur préparation |
EP0278656A1 (fr) * | 1987-02-02 | 1988-08-17 | Eli Lilly And Company | Procédé pour la préparation de pentahydrate de ceftazidime |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963542A (en) * | 1976-09-08 | 1990-10-16 | Takeda Chemical Industries, Ltd. | Cephalosporin derivatives |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
GB2052490B (en) * | 1979-05-25 | 1983-09-07 | Glaxo Group Ltd | Intermediates for use in the preparation of cephalosporin antibiotics |
US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
CH644609A5 (de) * | 1979-10-02 | 1984-08-15 | Glaxo Group Ltd | Cephalosporinantibiotikum. |
NL8005440A (nl) * | 1979-10-02 | 1981-04-06 | Glaxo Group Ltd | Cefalosporinen met antibiotische werking. |
US4332800A (en) * | 1979-10-12 | 1982-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4338313A (en) * | 1979-10-12 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
DE3006888A1 (de) * | 1980-02-23 | 1981-09-10 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
US4252802A (en) * | 1980-03-13 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins |
US4443444A (en) * | 1980-08-11 | 1984-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
DE3175156D1 (en) * | 1980-08-29 | 1986-09-25 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
FR2494276A2 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouvelles vinyl-3 cephalosporines, et leur preparation |
US4427677A (en) | 1980-12-31 | 1984-01-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
JPS57144291A (en) * | 1981-03-02 | 1982-09-06 | Ajinomoto Co Inc | Preparation of imidazoledicarboxylic acid derivative |
US4336253A (en) * | 1981-03-11 | 1982-06-22 | Eli Lilly And Company | Cephalosporin antibiotics |
JPS6011917B2 (ja) * | 1981-04-09 | 1985-03-28 | 山之内製薬株式会社 | 新規なセファロスポリン化合物 |
DE3118732A1 (de) * | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
GR75487B (fr) * | 1981-06-22 | 1984-07-23 | Fujisawa Pharmaceutical Co | |
US4577014A (en) * | 1981-09-08 | 1986-03-18 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4436912A (en) | 1981-09-08 | 1984-03-13 | Eli Lilly And Company | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor |
US4382931A (en) * | 1981-09-08 | 1983-05-10 | Eli Lilly And Company | 3'-Substituted quinolinium cephalosporins |
US4430499A (en) | 1981-09-08 | 1984-02-07 | Eli Lilly And Company | 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics |
US4382932A (en) * | 1981-09-08 | 1983-05-10 | Eli Lilly And Company | Isoquinolinium substituted cephalosporins |
US4406898A (en) * | 1981-09-08 | 1983-09-27 | Eli Lilly And Company | Oxazole and oxadiazole cephalosporins |
JPS5859991A (ja) * | 1981-09-14 | 1983-04-09 | Fujisawa Pharmaceut Co Ltd | 新規セフェム化合物 |
US4401668A (en) * | 1981-10-02 | 1983-08-30 | Eli Lilly And Company | Pyrazinium substituted cephalosporins |
US4402955A (en) * | 1981-10-02 | 1983-09-06 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4379787A (en) * | 1981-10-02 | 1983-04-12 | Eli Lilly And Company | Oximino-substituted cephalosporin compounds |
US4388316A (en) * | 1981-10-02 | 1983-06-14 | Eli Lilly And Company | Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins |
US4450270A (en) * | 1981-10-02 | 1984-05-22 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
US4406887A (en) * | 1981-10-13 | 1983-09-27 | Bristol-Myers Company | Method for treating resistant bacteria including anaerobes |
DE3265277D1 (en) * | 1981-11-13 | 1985-09-12 | Glaxo Group Ltd | Thiazole derivatives and their use in the manufacture of beta lactam antibiotics |
JPS58135872A (ja) * | 1981-11-13 | 1983-08-12 | グラクソ・グル−プ・リミテツド | 新規な化合物およびその製法 |
US4474954A (en) * | 1981-12-07 | 1984-10-02 | Bristol-Myers Company | Intermediates for cephalosporin derivatives |
US4394503A (en) * | 1981-12-07 | 1983-07-19 | Bristol-Myers Company | Cephalosporin derivatives |
US4501739A (en) * | 1982-01-19 | 1985-02-26 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
DE3207840A1 (de) * | 1982-03-04 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | "cephalosporinderivate und verfahren zu ihrer herstellung" |
CA1213882A (fr) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporines |
US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
EP0101148B1 (fr) * | 1982-04-29 | 1987-12-23 | Glaxo Group Limited | Dérivé de thiazole, procédé pour sa préparation ainsi que son application dans la fabrication des antibiotiques bêta-lactamiques |
ATE30724T1 (de) | 1982-06-28 | 1987-11-15 | Bristol Myers Co | Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten. |
IL69246A (en) * | 1982-08-07 | 1986-07-31 | Tanabe Seiyaku Co | 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
ES8502863A1 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
EP0113568B1 (fr) * | 1982-12-27 | 1990-04-04 | Eli Lilly And Company | Intermédiaires pour la préparation de ceftazidine, et procédé pour leur préparation |
EP0115770B2 (fr) * | 1983-01-07 | 1996-06-19 | Takeda Chemical Industries, Ltd. | Dérivés de thiazoles |
US4486586A (en) * | 1983-02-10 | 1984-12-04 | Bristol-Myers Company | Cephalosporin derivatives |
DE3313816A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
DE3316798A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
DE3316797A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
US4540779A (en) * | 1983-06-20 | 1985-09-10 | Eli Lilly And Company | Crystalline 7-(R)-amino-3-(1'pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound |
US4497811A (en) * | 1983-07-01 | 1985-02-05 | Seiji Shibahara | 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same |
JPS6061528A (ja) * | 1983-09-09 | 1985-04-09 | ブリストル―マイヤーズ スクイブ カンパニー | 嫌気性菌を包含する耐性バクテリアの処理法 |
AU566944B2 (en) * | 1983-10-07 | 1987-11-05 | Gist-Brocades N.V. | Preparation of 3-cephem derivatives |
JPS60178891A (ja) * | 1984-02-24 | 1985-09-12 | Kureha Chem Ind Co Ltd | セファロスポリン誘導体及び該誘導体を含有する医薬 |
US4537959A (en) * | 1984-03-26 | 1985-08-27 | Eli Lilly And Company | Crystalline cephalosporin antibiotic salt |
US4788185A (en) * | 1984-04-23 | 1988-11-29 | Takeda Chemical Industries, Ltd. | Cephalosporin compounds |
PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
EP0166580A3 (fr) * | 1984-06-25 | 1987-03-18 | Eli Lilly And Company | Préparation de ceftazidine |
US4616080A (en) * | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
US4626534A (en) * | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
EP0175544A3 (fr) * | 1984-09-17 | 1987-06-03 | Eli Lilly And Company | Procédé pour la préparation d'intermédiaires de céphalosporine |
US4659813A (en) * | 1984-11-08 | 1987-04-21 | Eli Lilly And Company | Crystallization process for ceftazidime derivative |
ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
US4703118A (en) * | 1985-04-08 | 1987-10-27 | Eli Lilly And Company | Synthesis of 3-iodomethyl cephalosporins |
US4692518A (en) * | 1985-11-06 | 1987-09-08 | Eli Lilly And Company | Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate monohydrate compound |
JPS62175489A (ja) * | 1986-01-29 | 1987-08-01 | Sanwa Kagaku Kenkyusho:Kk | 新規なセフアロスポリン誘導体及びその塩、これらの製法並びに該化合物を有効成分とする感染症治療剤 |
US5359057A (en) * | 1986-02-07 | 1994-10-25 | Hoffmann-La Roche Inc. | Acylation of amines |
JPS63107989A (ja) * | 1986-06-04 | 1988-05-12 | Tanabe Seiyaku Co Ltd | セファロスポリン化合物 |
AT387022B (de) * | 1986-06-04 | 1988-11-25 | Biochemie Gmbh | Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats |
IL82738A0 (en) * | 1986-06-16 | 1987-12-20 | Tanabe Seiyaku Co | Cephalosporin compounds,their preparation and pharmaceutical compositions containing them |
DE3778346D1 (de) * | 1986-09-10 | 1992-05-21 | Biochemie Gmbh | Stabile, kristalline form eines cefalosporin-zwischenproduktes. |
US4954624A (en) * | 1986-10-07 | 1990-09-04 | Sandoz Ltd. | Process for the production of cephalosporin derivatives |
US5021564A (en) * | 1987-02-02 | 1991-06-04 | Eli Lilly And Company | Process for preparing ceftazidime pentahydrate |
ATE97668T1 (de) * | 1987-06-25 | 1993-12-15 | Banyu Pharma Co Ltd | Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte fuer ihre herstellung. |
GB8802622D0 (en) * | 1988-02-05 | 1988-03-02 | Glaxo Group Ltd | Chemical compound |
IL92810A (en) * | 1988-12-27 | 1994-12-29 | Lilly Co Eli | The process of acylation of the history of nectar and intermediate material for this process |
US5194604A (en) * | 1990-06-29 | 1993-03-16 | E. R. Squibb & Sons, Inc. | Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains |
KR940000112B1 (ko) * | 1990-07-05 | 1994-01-05 | 주식회사 대웅제약 | 신규의 3-치환 세펨화합물 및 그의 제조방법 |
US5281589A (en) * | 1991-06-15 | 1994-01-25 | Cheil Foods & Chemicals, Inc. | 3-fused pyridiniummethyl cephalosporins |
KR100194994B1 (ko) * | 1993-06-05 | 1999-06-15 | 손경식 | 새로운 세펨 화합물 |
US6472383B1 (en) | 1994-04-25 | 2002-10-29 | Smithkline Beecham P.L.C. | Pharmaceutical formulations |
ATE252906T1 (de) * | 1994-04-25 | 2003-11-15 | Smithkline Beecham Plc | Pharmazeutische formulierung, die ein beta- lactamase hemmendes penem in kombination mit einem beta-laktam-antibiotikum enthalten und ihre verwendung zur behandlung von bakteriellen infektionen |
EP0760820A1 (fr) * | 1994-05-23 | 1997-03-12 | Korea Institute Of Science And Technology | Composes de cephalosporine et leurs procedes de preparation |
US5831085A (en) * | 1997-01-16 | 1998-11-03 | Lupin Laboratories Limited | Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof |
IN189047B (fr) | 1998-06-01 | 2002-12-14 | Ranbaxy Lab Ltd | |
US6930983B2 (en) * | 2000-03-15 | 2005-08-16 | Texas Instruments Incorporated | Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications |
KR100342600B1 (ko) | 2000-03-06 | 2002-07-04 | 한미정밀화학주식회사 | 신규한 티아졸 화합물 및 그의 제조 방법 |
KR100392409B1 (ko) | 2000-03-20 | 2003-07-22 | 한미정밀화학주식회사 | 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법 |
US6911441B2 (en) * | 2002-12-16 | 2005-06-28 | Akzo Nobel N.V. | Prolonged release pharmaceutical composition |
CN1312158C (zh) * | 2005-05-20 | 2007-04-25 | 天津市医药集团技术发展有限公司 | 一种头孢克肟的制备方法 |
WO2009049086A1 (fr) | 2007-10-09 | 2009-04-16 | Larry Sutton | Inhibiteurs de bêta-lactamase à large spectre |
CN101293891B (zh) * | 2008-06-12 | 2011-01-12 | 齐鲁安替制药有限公司 | 头孢他啶中间体的制备方法 |
EA028342B1 (ru) | 2011-09-09 | 2017-11-30 | Мерк Шарп И Доум Корп. | Способы лечения пневмонии |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
GEP20186874B (en) | 2013-03-13 | 2018-06-25 | Biopharma Antibiotics Ip Llc Theravance | Hydrochloride salts of an antibiotic compound |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
US20140275000A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
WO2014144295A1 (fr) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Compositions antibiotiques de ceftolozane |
WO2015035376A2 (fr) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée |
US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
CN106336418B (zh) * | 2016-08-19 | 2019-02-01 | 上海上药新亚药业有限公司 | 一种头孢他啶盐酸盐的固相合成法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4091209A (en) * | 1971-05-14 | 1978-05-23 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl or naphthylacetamido)]cephalosporins having a 2-haloalkylcarbamoyloxymethyl group at the 3-position |
US4093803A (en) * | 1971-05-14 | 1978-06-06 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins |
US4024137A (en) * | 1971-05-14 | 1977-05-17 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
US4079178A (en) * | 1971-05-14 | 1978-03-14 | Glaxo Laboratories Limited | Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position |
US4033950A (en) * | 1971-05-14 | 1977-07-05 | Glaxo Laboratories Limited | 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
US4024133A (en) * | 1971-05-14 | 1977-05-17 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins |
GB1399086A (en) | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
US4017515A (en) * | 1971-05-14 | 1977-04-12 | Glaxo Laboratories Limited | α-(Etherified oximino) carboxylic acids and acid chlorides |
US4064346A (en) * | 1971-05-14 | 1977-12-20 | Glaxo Laboratories Limited | 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
US3971778A (en) * | 1972-05-12 | 1976-07-27 | Glaxo Laboratories Limited | Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position |
GB1496757A (en) | 1973-12-21 | 1978-01-05 | Glaxo Lab Ltd | Cephalosporin derivatives |
US4144393A (en) * | 1973-12-21 | 1979-03-13 | Glaxo Laboratories Limited | 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group |
US4144392A (en) * | 1973-12-21 | 1979-03-13 | Glaxo Laboratories Limited | Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile |
US4162360A (en) * | 1973-12-21 | 1979-07-24 | Glaxo Laboratories Limited | 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives |
US4060686A (en) * | 1973-12-21 | 1977-11-29 | Janice Bradshaw | Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group |
US4032950A (en) * | 1974-12-06 | 1977-06-28 | Hughes Aircraft Company | Liquid phase epitaxial process for growing semi-insulating gaas layers |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
US4165430A (en) * | 1976-03-19 | 1979-08-21 | Glaxo Laboratories Limited | Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group |
US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
JPS52125188A (en) | 1976-04-14 | 1977-10-20 | Takeda Chem Ind Ltd | Cephalosporin derivatives and their preparation |
ZA781502B (en) | 1977-03-14 | 1979-09-26 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and processes for preparation thereof |
FR2384782A1 (fr) | 1977-03-25 | 1978-10-20 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
HU184680B (en) | 1977-04-02 | 1984-09-28 | Hoechst Ag | Process for producing ceph-3-eme-4-carboxylic acid derivatives containing amino-thiazolyl group in the side chain |
DE2716677C2 (de) | 1977-04-15 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | Cephemderivate und Verfahren zu ihrer Herstellung |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
GB1602725A (en) | 1977-04-27 | 1981-11-18 | Glaxo Operations Ltd | 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives |
AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
US4237128A (en) * | 1979-04-12 | 1980-12-02 | E. R. Squibb & Sons, Inc. | 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides |
US4394503A (en) * | 1981-12-07 | 1983-07-19 | Bristol-Myers Company | Cephalosporin derivatives |
-
1979
- 1979-05-24 AR AR276664A patent/AR229883A1/es active
- 1979-05-24 AR AR276665A patent/AR228726A1/es active
- 1979-05-25 NL NLAANVRAGE7904122,A patent/NL176855C/xx not_active IP Right Cessation
- 1979-05-25 SE SE7904576A patent/SE438507B/sv not_active IP Right Cessation
- 1979-05-25 IL IL57400A patent/IL57400A/xx unknown
- 1979-05-25 IT IT7949179A patent/IT1116198B/it active Protection Beyond IP Right Term
- 1979-05-25 DK DK216779A patent/DK157685C/da active
- 1979-05-25 FI FI791678A patent/FI67555C/fi not_active IP Right Cessation
- 1979-05-25 US US06/042,594 patent/US4258041A/en not_active Expired - Lifetime
- 1979-05-25 CA CA328,413A patent/CA1127633A/fr not_active Expired
- 1979-05-25 DE DE2921316A patent/DE2921316C2/de not_active Expired
- 1979-05-25 IL IL59793A patent/IL59793A/xx unknown
- 1979-05-25 CH CH491579A patent/CH646178A5/de not_active IP Right Cessation
- 1979-05-25 CH CH1707/80A patent/CH649556A5/de not_active IP Right Cessation
- 1979-05-25 ES ES480914A patent/ES480914A1/es not_active Expired
- 1979-05-25 PT PT69670A patent/PT69670A/pt unknown
- 1979-05-25 YU YU1231/79A patent/YU41635B/xx unknown
- 1979-05-25 PH PH22562A patent/PH16961A/en unknown
- 1979-05-25 NO NO791731A patent/NO155347C/no unknown
- 1979-05-25 NZ NZ190558A patent/NZ190558A/xx unknown
- 1979-05-25 LU LU81319A patent/LU81319A1/fr unknown
- 1979-05-25 AU AU47422/79A patent/AU524671B2/en not_active Expired
- 1979-05-25 SI SI7911231A patent/SI7911231A8/sl unknown
- 1979-05-25 ES ES480915A patent/ES480915A1/es not_active Expired
- 1979-05-25 PT PT69669A patent/PT69669A/pt unknown
- 1979-05-28 FR FR7913531A patent/FR2426695A1/fr active Granted
- 1979-08-08 IE IE1025/79A patent/IE49172B1/en not_active IP Right Cessation
- 1979-08-08 IE IE2453/80A patent/IE49173B1/en unknown
-
1980
- 1980-03-06 NL NL8001348A patent/NL8001348A/nl not_active Application Discontinuation
- 1980-04-01 NZ NZ193326A patent/NZ193326A/xx unknown
- 1980-04-09 FR FR8007929A patent/FR2445835A1/fr active Granted
- 1980-04-09 IL IL59793A patent/IL59793A0/xx unknown
- 1980-05-19 FI FI801609A patent/FI67705C/fi not_active IP Right Cessation
-
1981
- 1981-05-27 AT AT0239281A patent/AT370420B/de not_active IP Right Cessation
-
1982
- 1982-09-13 US US06/417,656 patent/US4600772A/en not_active Expired - Lifetime
- 1982-10-05 SI SI8212234A patent/SI8212234A8/sl unknown
- 1982-10-05 YU YU2234/82A patent/YU43097B/xx unknown
- 1982-11-16 SG SG583/82A patent/SG58382G/en unknown
- 1982-11-26 KE KE3252A patent/KE3252A/xx unknown
-
1983
- 1983-10-13 HK HK401/83A patent/HK40183A/xx not_active IP Right Cessation
-
1984
- 1984-05-28 SE SE8402887A patent/SE8402887D0/xx not_active Application Discontinuation
- 1984-12-30 MY MY17/84A patent/MY8400017A/xx unknown
-
1985
- 1985-01-14 NO NO850153A patent/NO850153L/no unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2465737A1 (fr) * | 1979-04-12 | 1981-03-27 | Squibb & Sons Inc | 7-(2-(2-amino-4-thiazolyl)-2 - ((1-carboxy-1,1 - dialkyl)alcoxyimino)acetamido)cephem sulfoxydes a action antibacterienne |
FR2476647A2 (fr) * | 1980-02-26 | 1981-08-28 | Roussel Uclaf | Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn |
EP0044238A1 (fr) * | 1980-06-30 | 1982-01-20 | Sanofi S.A. | Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant |
FR2560879A1 (fr) * | 1984-03-09 | 1985-09-13 | Glaxo Group Ltd | Procede de recuperation de l'antibiotique ceftazidime |
EP0192210A2 (fr) * | 1985-02-18 | 1986-08-27 | Fujisawa Pharmaceutical Co., Ltd. | Composés céphem et procédés pour leur préparation |
EP0192210A3 (en) * | 1985-02-18 | 1988-03-30 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and processes for preparation thereof |
US4861769A (en) * | 1985-02-18 | 1989-08-29 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
EP0278656A1 (fr) * | 1987-02-02 | 1988-08-17 | Eli Lilly And Company | Procédé pour la préparation de pentahydrate de ceftazidime |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2426695A1 (fr) | Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique | |
FR2378521A1 (fr) | Derives du carbostyrile, utiles notamment comme stimulants des centres b- adrenorecepteurs, et leur procede de preparation | |
BE901274A (fr) | Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments. | |
FR2385722A1 (fr) | Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique | |
BE904709A (fr) | Antibiotiques du type des macrolides et leur preparation. | |
BE904796A (fr) | Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant. | |
FR2366297A1 (fr) | Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique | |
FR2426694A1 (fr) | Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique | |
FR2364219A1 (fr) | Derives de thiazolidine, leur procede de preparation et leur application en therapeutique | |
BE900842A (fr) | Nouveaux complexes de platine et leur application en therapeutique. | |
FR2387229A1 (fr) | Dipyrido (4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant | |
PT69582A (fr) | Nouveaux acides lactame-n-acetiques et leurs amides leurs procedes de preparation et compositions pharmaceutiques | |
FR2422624A1 (fr) | Nouveaux agents anticholinergiques doues d'activite antisecretoire, leur procede de preparation et leurs utilisations | |
FR2445320A1 (fr) | Derives de phenoxypyridine et leur procede de preparation | |
FR2376858A1 (fr) | Nouvelles imidazo(1,2-a)quinoxalines substituees en position 4, leur procede de preparation et medicament les contenant | |
FR2423485A1 (fr) | Nouvelles 1,3-diaryl-2-imino-imidazolidines et 1,3-diaryl-2-imino-hexahydro-pyrimidines substituees, procedes de preparation de ces composes et medicaments les contenant | |
FR2417502A1 (fr) | Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation | |
FR2455572A1 (fr) | Derives de phenylethylamine, leur preparation et utilisation dans le traitement des affections cardiovasculaires, et compositions les contenant | |
FR2439786A1 (fr) | Nouvelles cephalosporines, leur procede de preparation et leurs applications therapeutiques | |
FR2362114A1 (fr) | Nouvelles substances a action stimulatrice sur les b-recepteurs adrenergiques, procedes pour leur preparation et leur utilisation therapeutique | |
FR2361371A1 (fr) | Nouvelles 2-phenylamino imidazolines-(2) substituees, leurs sels d'addition avec des acides, les medicaments les renfermant et procedes pour leur preparation | |
FR2451921A1 (fr) | Antibiotiques du type cephalosporine, leur procede de preparation et leur application therapeutique | |
FR2446829A1 (fr) | Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2441629A1 (fr) | Nouvelles cephalosporines, leur procede de preparation et leur application therapeutique | |
FR2355831A1 (fr) | Derives de benzazocine, leur procede de preparation et leur application therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CC | Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990) |
Free format text: 92C0184, 920511 |
|
CB | Supplementary protection certificate (spc) granted (law of 25 june 1990) |
Free format text: 92C0184, 790528 |
|
CL | Concession to grant licences |